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126a Sunday, February 26, 2012and YFP-tagged carboxy-terminal peptides of CaV1.3, CaV2.1, NaV1.4, and
NaV1.5 channels. Remarkably, the maximal FRET ratios, computed via 3
3-
FRET and E-FRETmethods, equaled unity, arguingwell for a 1:1 stoichiometry
of apoCaMbinding across CaV andNaV ion-channel families. These results mir-
ror functional findings that a single CaM, pre-associated to the carboxy-termini
of these channels, suffices for robust modulation of channel gating. More
broadly, these experiments underscore the power of FRET 2-hybrid assay to dis-
cern multiple aspects of binding interactions within a live-cell context.
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Ca2þ/calmodulin-dependent inactivation (CDI) of CaV channels plays a crucial
role in the homeostasis of intracellular Ca2þ, and serves as an ideal prototype
for investigating Ca2þ feedback regulation within biological systems. The pre-
vailing view of CDI mechanism is that Ca2þ-free calmodulin (apoCaM) preas-
sociates with the IQ domain of the proximal carboxy terminus of channels, and
this ‘resident’ calmodulin (CaM) acts as Ca2þ sensor to somehow trigger CDI
upon Ca2þ binding. The downstream CaM/channel configurations leading to
CDI are complex and under investigation at present. Contrasting with this com-
plexity, CaV1.3 and CaV1.4 feature a long-carboxy-tail splice variant that min-
imizes CDI by a beautifully simple mechanism. We recently combined
electrophysiology and a genetically encoded fluorescent sensor to record CDI
and CaM concentration simultaneously (Nature463:968), thereby demonstrat-
ing that the distal-carboxy-tail (DCT) harbors an ICDI module that competes
with apoCaM for binding to the IQ domain. By kicking off apoCaM, ICDI di-
minishes CDI in an eminently straightforward manner; thus, the IQ/ICDI com-
plex now looms as a simplified prototype for novel channel modulators, and as
an easy entrez into complex CaM/channel configurations underlying CDI.
Here, we perform alanine-scanning mutagenesis of the entire IQ domain and
ICDI domain. Hotspot mutations which reduce IQ/ICDI binding affinity also
commensurately diminish ICDI function (i.e., permit restoration of CDI). Fur-
thermore, the ensemble of effects can be well fit with a Michaelis-Menten equa-
tion incorporating the presence of a competitive inhibitor. Thus, the collection
of hotspots can be used to identify the minimal functional segments of IQ/ICDI
interaction to facilitate structure building, and to provide clues for designing
small peptides and/or molecules that regulate CDI of specific CaV channels.
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The Cardiac L-Type Calcium Channel Distal Carboxyl Terminus is
a Reverse use Dependent Inhibitor of Ca Current in Cardiomyocytes
Shawn M. Crump, Jonathan Satin.
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Background. The LTCC distal C-terminus (DCT) is proteolytically cleaved,
and re-associates with the LTCC complex to regulate calcium channel function.
DCT reduces LTCC barium current (IBa,L) in reconstituted channel complexes
and mediates the fight or flight response in DCT knockout mice; yet the contri-
bution of DCT to ICa,L in native systems is unexplored. This study examines
the beat-to beat contribution of DCT to LTCC calcium homeostasis in native
cardiomyocytes.
Methods. We measured LTCC current with DCT co-expressed in cardiomyo-
cytes. We also heterologously co-expressed DCT and CaV1.2 constructs
with a stop corresponding to the predicted proteolytic cleavage site,
Cav1.2D1801, and a shorter deletion corresponding to well-studied construct,
Cav1.2D1733 along with CaVb2 subunits.
Results. DCT was found to inhibit IBa,L, but not ICa,L in cardiomyocytes.
DCT blocked IBa,L carried by both Cav1.2D1801 and Cav1.2D1733 in HEK
cells. However, DCT inhibited ICa,L carried by Cav1.2D1801 but not
Cav1.2D1733 channels. As CaM and DCT have adjoining interaction sites
on CaV1.2, we tested if exogenous CaM (CaMex) interferes with DCT current
inhibition in cardiomyocytes and HEK systems. CaMex relieved DCT block in
both systems and both channel variants. Addition of CaM1234 did not relieve
DCT current inhibition or have an additive effect. DCT did not alter voltage
dependence, or activation kinetics. The selective block of IBa,L suggested
that DCT activity may be relieved under conditions of elevated Ca.
Conclusions. DCT blockade of LTCC is apparent only when Ca is not the
charge carrier. Therefore, our data motivates the new hypothesis that DCT is
a native reverse use-dependent inhibitor of LTCC current.
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UMDNJ-NJMS, Newark, NJ, USA.Previoulsy (Biophys. Meetings 2010 and 2011), we showed that inactivation of
L-type Ca2þ channels containing the g1 subunit changes during cell cycle. The
half-inactivation voltage is very negative (in the 70 - 50 mV range) in cells
at the G1 phase, but also after serum starvation, or after the ER shock.
Here we report that the novel regulatory pathway is membrane-delimited be-
cause it depends on cholesterol and sphingolipids. Alterations of the membrane
lipid fluidity (e.g., addition of Triton X-100) affected inactivation regardless of
the g1 subunit. However, variousmanipulations withmembrane cholesterol, ce-
ramide, and/or shpingosine were efficient only when the g1 subunit was present.
Although tested positively in our experimental conditions, phosphoinositides, C-
8-ceramide-1-phosphate, sphingosine-1-phosphate, and glycosphingolipid
GM1 did not act specifically on inactivation with the g1 subunit.
When cholesterol was depleted from the membrane, or upon application of
sphingosine, ceramide-C2, or ceramide-C8, inactivation shifted to the 70 -
50 mV range. Isomers epi-cholesterol and dihydro-ceramide-C2 did not
act. Because ceramide and sphingosine strongly activate phosphatases PP1
and PP2A, phosphatase inhibitors calyculin A, or tautomycetin, were applied
in order to prevent a rapid current run-down. Thus, a role of phosphoryla-
tion-dependent pathways can be excluded as well.
We compared the membrane cholesterol content in cells at different cell-cycle
stages, but did not find any significant difference. However, the membrane con-
tents of sphingosine and ceramide are well known to change during cell cycle.
Therefore, we propose that the enhancement of inactivation of L-type channels
by the g1 subunit is dependent on sphingosine and ceramide. Possibly, the
sphingolipids interact directly with the subunit. The large scale of changes of
inactivation properties due to these interactions allows efficient spatiotemporal
tuning of functional availability of L-type Ca2þ channels.
Supported by R01MH079406.
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tions in the Pore of CaV1.2
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Eugen Timin, Steffen Hering.
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Voltage sensors initiate the closed - open transitions in the ion conducting pore.
Here we consecutively neutralized the charges of the four S4 segments (IS4-
IVS4) of CaV1.2. The channel construct lacking charges in IIS4 (IIS4N) con-
ducted barium currents. Surprisingly, charge neutralization accelerated channel
closure and diminished shifts of the activation curves also in S6 mutants (IS6:
G432W/IIS4N, IIS6: A780T/IIS4N, IIIS6: G1193T/IIS4N, IVS6: A1503G/
IIS4N). Such a rescue of S6-mediated gating perturbations is exemplified for
the IVS6 mutation A1503G. A1503G induced a22.651.2 mV shift of the ac-
tivation curve to the left that was diminished by charge neutralization in IIS4.
Gating disturbances induced by pore mutations upstream and downstream of
G432, G1193 and A1503 were unaffected.
Thermodynamic analysis reveals that seg-
ment IIS4 interacts (energetically cou-
pled) with a ring of small homologous
amino acids G432, A780, G1193 and
A1503 (G/A/G/A ring, Depil et al. 2011)
in all four pore forming S6 segments.
The research was funded by the Austrian
Science Fund (FWF): grant P22600-B12
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Temperature Effects on Pharmacologic Enhancement of L-Type Calcium
Current
Zhi Su, Xiaoqin Liu, Ruth L. Martin, Bryan F. Cox, Gary A. Gintant.
Abbott Laboratories, Abbot Park, IL, USA.
L-type calcium current (Cav1.2) plays a key role in modulation of multiple car-
diovascular functions. Therefore, Cav1.2 calcium current assay is useful in
screening discovery compounds for potential cardiovascular (CV) liabilities.
L-type calcium current itself is highly sensitive to temperature. However, it
is not known if drug effects on this current are influenced by temperature. Using
whole-cell voltage clamp techniques, we compared the effects of room (22-24
C) and physiological (37 C) temperatures on the current in the absence and
presence of a calcium current activator (TTYC) in CHO cells stably expressing
L-type calcium channels. Under our experiment conditions (2 mM [Ca2þ]o),
calcium current amplitude in CHO cells was increased approximately 4-fold
with warming from 24 to 37 C; the half maximal activation voltage (V1/2)
was shifted from 6.4 mV (24 C) to 17 mV (37 C). The calcium channel
activator TTYC (0.3 uM, Su et al. 2010) increased peak current by 925 10 %
Sunday, February 26, 2012 127aat 24 C but only 205 3.0% at 37 C; time to peak increased from 2.45 0.4 to
34.55 2.4 ms (control vs TTYC) at room temperature and from 5.65 0.4 to
1305 14 ms at 37 C. TTYC produced similar V1/2 shifting (to the left) in the
activation curves at room (10.2 vs. 2.2 mV) and physiology (23.5 vs.
14.2 mV) temperatures. In summary, these results confirm that temperature
is an important modulator of the L-type calcium channels expressed in CHO
cells, and further demonstrate that the natural modulator (temperature) of
L-type calcium channel influences its pharmacological responses to a channel
activator in terms of peak current amplitude and biophysical properties.
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CACNA1F encodes the alpha1 subunit of retina-specificCav1.4 voltage-gated L
type calcium channels. Mutations in this gene cause congenital stationary night
blindness type 2A (CSNB2), Aland Island eye disease (AIED) and cone-rod dys-
trophy type 3 (CORDX3). The clinical phenotypes of these eye diseases vary
substantially regarding the ratio of rod to cone functional impairment. The rea-
sons for this variability are not known. To gainmore insights into the pathophys-
iology caused by loss of Cav1.4 function we analyzed the visual phenotype of
Cav1.4-deficient mice. To this end, we combined immunohistochemistry, elec-
troretinography (ERG) and vision-dependent behavioral testing. Immunohisto-
chemical analysis using synaptic and postsynaptic markers revealed severe
synaptic defects in Cav1.4-deficient mice. Heterozygous Cav1.4 mice showed
mosaic synaptic defects most probably caused by random X-chromosomal
inactivation of the healthy allele. Electroretinography revealed a loss of scotopic
and photopic photoreceptor function. This loss of retinal network function
resulted in impaired perfomance of Cav1.4 knockout mice in a water maze-
based behavioral test of rod and cone function. In conclusion, loss of Cav1.4
channels strongly impairs rod and cone retinal function and vision in mice.
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Shuyang Li1, Hucheng Zhao2, Ping liu3, Dongyue Huang2, Daizong Li4,
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MO, USA, 2Washington University Pain Center and Department of
Anesthesiology, Washington University School of Medicine, St. Louis,
MO, USA, 3Washington University Pain Center and Department of
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Multiple mutations in human CACNA1A, the gene encoding the pore-forming
CaV2.1 subunit of P/Q-type VGCCs, have been associated with many neuro-
logical diseases including familial hemiplegic migraine type 1 (FHM-1), ep-
isodic ataxia type 2 (EA2) and epilepsy. The effects of many CACNA1A
mutations on the biophysical properties of the P/Q-type channels have been
extensively studied. However, questions remain as to whether and how these
mutations affect CaV2.1 protein expression and/or the plasma membrane traf-
ficking. To develop tools in exploring the mechanisms underlying CaV2.1 traf-
ficking, we inserted a 15 amino acids epitope (PQ-I) in the IS5-S6 loop of
human CaV2.1 into the hepatitis B virus core (HBc) protein. The virus-like
particles self-assembled from the HBc-PQ-I fusion protein was used to immu-
nize mice to obtain antisera. The PQ-I antibody specifically recognized human
CaV2.1 subunits expressed in HEK293 cells but not CaV1.2, CaV2.2 or
CaV2.3. Next, we expressed EGFP-tagged wild-type or mutant CaV2.1 sub-
units in HEK cells and examined CaV2.1-immunoreactivity (CaV2.1-ir) in
transfected, non-permeabilized cells with PQ-I antibody. EGFP signals were
observed in both the plasma membrane and intracellular compartments. In
contrast, CaV2.1-ir was restricted to the cell surface. Our data showed that
missense FHM-1 mutations did not affect the expression or the plasma mem-
brane trafficking of CaV2.1 subunits. On the contrary, the nonsense EA2 mu-
tation Y1854X resulted in a significant reduction of both CaV2.1 protein
expression as well as its efficiency of trafficking to the plasma membrane.
This may account for the diminished current through Y1854X mutant chan-
nels. Furthermore, the PQ-I antibody did not attenuate P/Q-type currents,
nor did it affect the effect of P/Q-channel blocker-agatoxin-IVA, suggestingthat it can be used to track CaV2.1 trafficking in vivo without perturbing its
physiological functions.639-Pos Board B425
Long QT Syndrome-Associated F97C and S141R CaV-3 Mutations Exert
Pleiotropic Effects on Cardiac L-Type Calcium Channels
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Caveolin-3 (Cav-3) is a critical scaffolding protein essential for caveolae for-
mation. In cardiomyocytes, caveolae serve as important Ca2þ microdomains
where several ion channels localize including voltage-gated Naþ and L-type
Ca2þ channels (LTTCs). Our previous studies have shown that Long QT Syn-
drome (LQTS)-associated Cav-3 F97C and S141R mutations increased sodium
channel late current, but it is unknown if these mutations impact LTTCs. We
co-expressed Cav-3 WT, F97C, or S141R with Cav1.2 þ Cavb2cN4 in HEK
293 cells and measured LTCC currents (ICa,L) using whole-cell perforated
patch clamp with 10 mM Ca2þ or 10 mM Ba2þ as the charge carrier. Cav-3
S141R transfected cells showed increased ICa,L peak current density
(13.9551.86 pA/pF, p<0.05) compared to F97C (7.5951.99 pA/pF) and
WT (9.4752.38 pA/pF). Analysis of ICa,L inactivation shows that Cav-3
F97C (r100: 0.3550.03) slows inactivation compared to S141R and WT
(0.2450.04 and 0.1350.03, respectively; p<0.05). However, there were no
significant differences in IBa,L current density or inactivation observed between
Cav-3 WT, F97C, and S141R. Experiments were also performed in mouse neo-
natal ventricular myocytes transfected with Cav-3 WT, F97C, or S141R. Cav-3
S141R (6.9850.97 pA/pF) increased peak ICa,L current density compared to
F97C and WT (2.6250.87 and 3.7650.72 pA/pF, respectively; p<0.05).
Analysis of ICa,L inactivation showed that both Cav-F97C and S141R (r75:
0.1350.02 and 0.1350.02, respectively, p<0.05) slowed inactivation com-
pared to WT (0.0550.02). LQT Cav-3 F97C and S141R mutations alter
calcium-dependent LTTC function by reducing Ca-dependent inactivation
and for S141R increasing current density. In conclusion, these results suggest
a newly identified role in which Cav-3 is part of the complex which regulates
calcium-dependent inactivation of cardiac LTTCs. Furthermore, the LQT
Cav-3 mutations, F97C and S141R, show important gain-of-function effects
which will prolong repolarization and contribute to arrhythmogenesis.
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Although the effect of aldosterone beyond the epithelia is now well recognized,
specific action through the mineralocorticoid receptor (MR) in heart is still mat-
ter of debate. In the past decade, we have accumulated evidence, both ex vivo
and in vivo, that modulation of Ca2þ signaling, especially Ca2þ influx via L-
type Ca2þ channel (Cav1.2), is a central factor in the cardiac action of aldoste-
rone. Even if our results established that a specific transcriptional upregulation
is involved in the effect of aldosterone on Cav1.2, it cannot be concluded
whether this genomic effect is direct or indirect. The effect of the mineralocor-
ticoid, aldosterone, on the regulation of the cardiac Cav1.2 expression was in-
vestigated in primary cultures of neonatal rat ventricular myocytes (nRVM). By
use of quantitative real time RT-PCR, we found that aldosterone increased the
Cav1.2 mRNA amount in time- and dose-dependent manner. This up-
regulation appeared as early as 1hour of incubation even with 1 nM aldoste-
rone. Inspection of the upstream promoter region from rat Cav1.2 encoding
gene, revealed one putative hormone response element, GRE. The activity of
the promoter-luciferase reporter gene constructs in transfected nRVMs showed
similar time- and dose-dependent stimulation with aldosterone. We will exam-
ine the intracellular trafficking of MR in nRVMs using a fusion protein of green
fluorescent protein and human MR. Selectivity of these effects will be tested as
well as electrophoretic mobility shift assays to identify the region of the cac-
na1c promoter that can bindMRs. The data will provide new insights in the mo-
lecular mechanisms underlying the regulation of Cav1.2 channel expression by
mineralocorticoids.
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Calcium-Dependent Inactivation of Neuronal L-Type Calcium Channels
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In neurons, L-type voltage-gated Ca2þ channels (L-channels) provide Ca2þ sig-
nals that help control gene expression. Consequently, regulation of L-channel
